Weiss Multi-Strategy Advisers LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$95,000
-24.0%
27,5000.0%0.00%0.0%
Q2 2018$125,000
-52.7%
27,500
-65.6%
0.00%
-62.5%
Q1 2018$264,000
-59.9%
80,000
-52.7%
0.01%
-52.9%
Q4 2017$659,000
+93.8%
169,034
+238.1%
0.02%
+30.8%
Q1 2017$340,000
-38.2%
50,000
-50.0%
0.01%
-51.9%
Q4 2016$550,000100,0000.03%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders